Protagonist Therapeutics, Inc. (PTGX): A Cheap Biotech Stock to Invest In Now
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...
Protagonist Therapeutics (PTGX) Receives a Buy from Truist Financial
In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Protagonist Therapeutics (PTGX – Research ...
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Receives $56.00 Consensus Price Target from Analysts
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) has earned a consensus rating of “Buy” from the nine ...
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Shares Bought by KBC Group NV
KBC Group NV increased its position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 54.4% in the 4th quarter ...
Protagonist Therapeutics (PTGX) Gets a Buy from TD Cowen
In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report), with a ...
JMP Securities maintains PTGX stock with $58 target
JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...
news.stocktradersdaily6d
Objective long/short (PTGX) Report
Buy PTGX near 38.8 target 45.14 stop loss @ 38.69 Details The technical summary data tells us to buy PTGX near 38.8 with an upside target of 45.14. This data also tells us to set a stop loss @ 38.69 ...